Credit rating
Announcement under Regulation 30 (LODR)-Credit Rating 2 Sep - ICRA reaffirmed OCCL’s AA-/A1+ ratings for ₹269 crore bank facilities, including enhanced limits.
Source: Bse
OCCL Limited (OCCLLTD)
Small CapIndustrials stocks · Small cap · NSE
OCCL Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 21 Oct, 05:57 pm ISTDetails
Quote21 Oct, 05:57 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result30 Jul, 08:35 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
53NeutralSMA20 +21.8% / mo · MACD −
Stock trend: 58
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
OCCLLTDD candles · FIT view+61.1%Latest close ₹165.14 on 2026-10-21
Bar
-12.8%
RSI
39
MACD hist
-4.31
52W pos
51%
2026-10-21O ₹189.40H ₹192.07L ₹162.00C ₹165.14Vol 5.6L sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
OCCLLTDNifty India ManufacturingNifty 500
- OCCLLTD
- +21.2%
- Nifty 500
- -6.5%
- Nifty India Manufacturing
- -7.7%
- Vs Nifty 500
- +27.7 pp
Chart stats
21 Oct 2026- From 52W high
- -34.2%
- 52W range position
- 51%
- ATR (14)
- 9.7%
- Volume vs 20D
- 2.03x
- Avg traded value
- ₹6.1 Cr
- 20D price channel
- ₹150 - ₹251
₹251
₹75.7 - ₹251
₹16.1
Latest completed session
20-session average
93.4% annualized volatility
Research snapshot
What the evidence says now
Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is consistent.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · UNDERVALUED64
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Excellent100
Revenue +78.9% · PAT +207.7% YoY
Technical
Neutral53
Price trend and sector-relative-strength timing.
Valuation
Legacy model+72.0%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence71
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +79% YoY · PAT +208% YoY · margin expansion · +48% QoQ · operating leverage
Filed 30 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹220 Cr | +78.9% | +47.6% |
| EBITDA | ₹62 Cr | +138.5% | +158.3% |
| Operating margin | 28.0% | +700 bps | +1200 bps |
| PAT | ₹40 Cr | +207.7% | +110.5% |
| PAT margin | 18.2% | +761 bps | +543 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 12.90
- P/B
- 2.29
- EV/EBITDA
- 7.05
- Market Cap
- 988.00Cr
Profitability
- ROE
- 12.20%
- ROCE
- 13.00%
- ROA
- 12.46%
- Dividend Y
- 1.42%
Growth (CAGR)
- Revenue 5Y
- —
- EPS 5Y
- 88.98%
- Revenue 3Y
- 1260.00%
- EPS 3Y
- 222.45%
Balance Sheet
- Debt/Equity
- 0.21
- Interest Coverage
- 20.67×
- Altman Z
- 6.38
- Book Value
- 86.30
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 1/5
- OCF
- 11.00 Cr
- EPS TTM
- 14.98
Shareholding
- Promoter Hold
- 51.76%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 96%
Financial History
Updated 21/10/2026
Revenue
₹ CrLatest: 220+47.7% vs prev
Net Profit
₹ CrLatest: 40.0+110.5% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term uptrend intact. RSI 39. Wait for confirmation.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 rising (~17.9% over last month) — short-term momentum positive.
- RSI(14) at 39 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 34% off 52W high · 118% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
87
RS percentile
Stage 2 UptrendEstablished S2
1M return
+7.1%
3M return
+21.2%
6M return
+63.1%
1Y return
+20.7%
RS 1D
-4
RS 20D
+3
Sector rank
#2
Industry rank
#6
Stage evidence
- Price is 22.3% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +11.9%.
- Both 3-month and 6-month returns are positive.
50-DMA
price below
200-DMA
price above
S2 entered
17 Jun 2026
S2 age
88 trading sessions
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
262 observations
21 Oct 2026Value 134.1-12.40%
RS vs Nifty 500134
Valuation & peers
U-Score 64 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 64 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Deep Value
Fundamental score breakdown
U band · UNDERVALUEDValuation22/30
Growth24/25
Quality3/20
Balance Sheet10/15
Cash Flow1/10
Piotroski
8/9 (+5)
Penalties
-1
Raw sum
64
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
64/100 · legacy band UNDERVALUED
Positive drivers
- Piotroski is strong at 8/9.
- Fair-value margin of safety is positive at 72.0%.
- Growth contributes 24/25 to the score.
Main drags
- Penalty bucket subtracts 1 points.
- Cash flow is weaker at 1/10; verify the latest quarterly trend.
- Quality is weaker at 3/20; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
12.9
PB
2.3
EV/EBITDA
7.0
ROE
12.2%
ROCE
13.0%
FCF Yield
—
Debt/Equity
0.2
MoS
+72.0%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
64
Previous: 63 (+1)
Legacy U-Score band
UNDERVALUED
Previous: UNDERVALUED
Margin of safety
+72.0%
Previous: +67.7%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
59
59
59
59
59
59
59
62
62
62
63
63
Factor attribution
Valuation
22+1
was 21
Modelled fair value
Graham Number
₹170.55
+3.2% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹588.71
+72.0% MoS
PEG
0.09
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
SRHHYPOLTD
Small
Sree Rayalaseema Hi-Strength Hypo Limited
Specialty Chemicals
match 167
71
9.4
10.5%
+69%
UNDERVALUED
MWL
Small
Mangalam Worldwide Limited
Specialty Chemicals
match 165
55
21.5
18.0%
+44%
FAIR VALUE
KRONOX
Small
Kronox Lab Sciences Limited
Specialty Chemicals
match 165
58
26.7
26.8%
+34%
FAIR VALUE
TRANSPEK
Small
Transpek Industry Limited
Specialty Chemicals
match 165
55
18.8
6.1%
+49%
FAIR VALUE
SADHNANIQ
Small
Sadhana Nitrochem Limited
Specialty Chemicals
match 162
18
—
-23.5%
—
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
OCCL Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
71Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 66th percentile of the scored universe and 64th percentile within Industrials. Main check: cash conversion is weak at 43/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
26 docs text-extracted · 12 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
66th percentile
overall median 67 · Industrials: 64th pctile, median 68 · Small: 69th pctile, median 66
Evidence depth
Financial-only
26 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
78
strong · holding, pledge, alignment
Cash flow
43
weak · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
68
acceptable · capital discipline
Results
87
strong · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸4/4 latest quarters had positive YoY revenue growth.
- ▸4/4 latest quarters had positive YoY PAT growth.
- ▸Latest 3 quarters had positive YoY PAT growth.
Trust risks
- ▸Only 1 years of positive FCF.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching OCCL Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Annual reportAug 2026
Aug 2026 · Notice Of 4Th Annual General Meeting Of The Members Of OCCL Limited 4 Aug - Annual report FY26 sent; AGM on August 27, 2026, remote e-voting August 24-26, cutoff August 20.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Aug - Newspaper advertisement regarding the dispatch of 4th Annual General Meeting Notice
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Aug - Newspaper Publication dated 04.08.2026 for Pre- Dispatch of Notice of 4th annual general meeting of the Company
Source: Bse
Concall transcript
Compliances-Reg.24(A)-Annual Secretarial Compliance 27 May - FY26 secretarial compliance report filed; one investor call transcript delayed to 11/08/25.
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2026 from bse
Source: Bse
Concall transcriptFeb 2026
Feb 2026 · Transcript
Source: Company Ir
Investor presentationFeb 2026
Feb 2026 · PPT
Source: Bse
Investor presentationFeb 2026
Feb 2026 · PPT
Source: Bse
Concall transcriptNov 2025
Nov 2025 · Transcript
Source: Bse
Investor presentationNov 2025
Nov 2025 · PPT
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.